PagrindinisPRGO • NYSE
add
Perrigo Company PLC
Ankstesnė uždarymo kaina
14,91 $
Dienos intervalas
14,18 $ - 15,02 $
Metų intervalas
12,17 $ - 30,93 $
Bendroji vertė rinkoje
2,07 mlrd. USD
Vidutinė prekybos apimtis
3,67 mln.
Kainos ir pajamų santykis
-
Pajamos iš dividendų
7,73 %
Pagrindinė akcijų birža
NYSE
Aktualios naujienos
Apie
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Generalinis direktorius
Įkurta
1887
Svetainė
Darbuotojų skaičius
8 379